Sign inGet started

Green Jeremy

Insider CIK 1650527 · ARRY 10% owner · FOLD 10% owner · VAPO 10% owner · XERS 10% owner · MDVL Director, 10% owner · NLTX 10% owner · ALDR Director, 10% owner · FATE Director, 10% owner · IGMS Director, 10% owner · ANNX 10% owner · BCEL 10% owner · NRIX 10% owner · SYRS 10% owner · ALLK 10% owner · ATRA Director · STOK 10% owner · GRTS 10% owner · ABSI Director, 10% owner · STTK Director, 10% owner · TRDA 10% owner · REPL 10% owner · AKRO 10% owner · BEAM 10% owner · PLRX 10% owner · TCRR 10% owner · ALVR 10% owner · CABA 10% owner · HOOK 10% owner · AUGX Director, 10% owner · ADCT 10% owner · APRE 10% owner · RPTX 10% owner · KYMR 10% owner · SNCE Director, 10% owner · RYZB 10% owner · ADGI 10% owner · VERV 10% owner · ZYME 10% owner · ATTO 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-07782,854— $00SEC↗
ATTO Attovia Therapeutics, Inc. P Buy2026-08-062026-08-07400,000$17.00 $6.80M1,182,854SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-07782,854— $0782,854SEC↗
ATTO Attovia Therapeutics, Inc. P Buy2026-08-062026-08-07200,000$17.00 $3.40M982,854SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion deriv2026-08-062026-08-07782,854— —0SEC↗
ATTO Attovia Therapeutics, Inc. P Buy2026-08-062026-08-07400,000$17.00 $6.80M1,182,854SEC↗
ATTO Attovia Therapeutics, Inc. P Buy2026-08-062026-08-07200,000$17.00 $3.40M982,854SEC↗
ATTO Attovia Therapeutics, Inc. C Conversion2026-08-062026-08-07782,854— —782,854SEC↗
ATRA Atara Biotherapeutics, Inc M Exercise deriv2026-07-222026-07-24101,089— $00SEC↗
ATRA Atara Biotherapeutics, Inc M Exercise deriv2026-07-222026-07-2438,735— $00SEC↗
ATRA Atara Biotherapeutics, Inc M Exercise deriv2026-07-222026-07-2455,387— $00SEC↗
ATRA Atara Biotherapeutics, Inc M Exercise2026-07-222026-07-24195,211— $0636,912SEC↗
ATRA Atara Biotherapeutics, Inc F Tax w/h2026-07-222026-07-2460— $0636,852SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2026-06-122026-06-1587,900— $087,900SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2026-04-202026-04-22266,280— $00SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2026-04-202026-04-22162,013— $00SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2026-04-202026-04-22266,280— $0502,769SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2026-04-202026-04-22162,013— $02,755,086SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2026-04-202026-04-223,691,324— $03,893,674SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2026-04-202026-04-223,691,324— $00SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2026-04-202026-04-23266,280— $0502,769SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2026-04-202026-04-23266,280— $00SEC↗
FATE FATE THERAPEUTICS INC J Other2026-04-202026-04-228,977,624— $00SEC↗
FATE FATE THERAPEUTICS INC J Other2026-04-202026-04-228,977,624— $012,884,277SEC↗
ADCT ADC Therapeutics SA S Sale2026-04-022026-04-022,529,491$3.28 $8.30M10,265,297SEC↗
ADCT ADC Therapeutics SA S Sale2026-04-022026-04-022,634,506$3.28 $8.64M12,666,731SEC↗
ADCT ADC Therapeutics SA S Sale2026-04-012026-04-02169,265$3.80 $643.2K15,301,237SEC↗
ADCT ADC Therapeutics SA S Sale2026-04-012026-04-02162,517$3.80 $617.6K12,794,788SEC↗
ADCT ADC Therapeutics SA S Sale2026-03-312026-04-02188,407$3.75 $706.5K12,957,305SEC↗
ADCT ADC Therapeutics SA S Sale2026-03-312026-04-02196,229$3.75 $735.9K15,470,502SEC↗
ADCT ADC Therapeutics SA P Buy deriv2025-10-272025-10-283,846,153$3.90 $15.00M3,846,153SEC↗
ADCT ADC Therapeutics SA P Buy deriv2025-10-272025-10-283,846,153$3.90 $15.00M3,846,153SEC↗
STTK Shattuck Labs, Inc. A Award deriv2025-08-252025-08-264,097,730— $04,097,730SEC↗
STTK Shattuck Labs, Inc. A Award deriv2025-08-252025-08-264,097,730— $07,198,553SEC↗
IGMS IGM Biosciences, Inc. D To issuer deriv2025-08-142025-08-157,199,325— $00SEC↗
IGMS IGM Biosciences, Inc. D To issuer deriv2025-08-142025-08-15667,666— $00SEC↗
IGMS IGM Biosciences, Inc. D To issuer2025-08-142025-08-152,964,843— $00SEC↗
STTK Shattuck Labs, Inc. A Award deriv2025-07-142025-07-1633,150— $033,150SEC↗
IGMS IGM Biosciences, Inc. A Award2025-06-302025-07-02828— $02,964,843SEC↗
ADCT ADC Therapeutics SA P Buy deriv2025-06-112025-06-1315,734,267$3.43 $53.97M15,734,267SEC↗
ADCT ADC Therapeutics SA P Buy deriv2025-06-112025-06-1312,465,234$3.43 $42.76M12,465,234SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2025-05-292025-05-3055,000— $055,000SEC↗
IGMS IGM Biosciences, Inc. A Award2025-03-312025-04-02828— $02,964,015SEC↗
IGMS IGM Biosciences, Inc. A Award2024-12-312025-01-021,734— $02,963,187SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2024-12-202024-12-2656,331$1.68 $94.6K502,769SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2024-12-202024-12-26116,261$8.40 $976.6K2,755,086SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2024-12-202024-12-26116,261$8.40 $976.6K2,638,825SEC↗
FATE FATE THERAPEUTICS INC P Buy2024-12-202024-12-26397,964$1.68 $668.6K12,884,277SEC↗
FATE FATE THERAPEUTICS INC J Other2024-12-202024-12-261,084,936$1.68 $1.82M11,743,010SEC↗
FATE FATE THERAPEUTICS INC J Other2024-12-202024-12-261,084,936$1.68 $1.82M12,827,946SEC↗
FATE FATE THERAPEUTICS INC S Sale2024-12-202024-12-26341,633$1.68 $573.9K12,486,313SEC↗
FATE FATE THERAPEUTICS INC C Conversion deriv2024-12-122024-12-166,022— $02,755,086SEC↗
FATE FATE THERAPEUTICS INC C Conversion2024-12-122024-12-1630,110— $012,827,946SEC↗
ADCT ADC Therapeutics SA P Buy2024-12-112024-12-1350,000$3.81 $190.5K15,666,731SEC↗
ADCT ADC Therapeutics SA P Buy2024-12-112024-12-1350,000$3.81 $190.5K13,145,712SEC↗
ADCT ADC Therapeutics SA P Buy2024-12-112024-12-1350,000$2.28 $114.0K15,616,731SEC↗
ADCT ADC Therapeutics SA P Buy2024-12-112024-12-1350,000$2.28 $114.0K13,095,712SEC↗
ADCT ADC Therapeutics SA J Other deriv2024-12-042024-12-0626,656$2.07 $55.2K8,136,609SEC↗
ADCT ADC Therapeutics SA J Other deriv2024-12-042024-12-0626,656$2.07 $55.2K8,163,265SEC↗
ADCT ADC Therapeutics SA J Other deriv2024-12-042024-12-0626,656$2.07 $55.2K6,133,837SEC↗
STTK Shattuck Labs, Inc. S Sale2024-12-042024-12-06133,371$1.25 $166.7K5,406,353SEC↗
STTK Shattuck Labs, Inc. J Other2024-12-042024-12-061,026,888$1.25 $1.28M5,539,724SEC↗
STTK Shattuck Labs, Inc. J Other2024-12-042024-12-061,026,888$1.25 $1.28M4,512,836SEC↗
STTK Shattuck Labs, Inc. P Buy2024-12-042024-12-06133,371$1.25 $166.7K5,539,724SEC↗
ADCT ADC Therapeutics SA J Other2024-12-042024-12-0650,672$2.07 $104.9K13,045,712SEC↗
ADCT ADC Therapeutics SA J Other2024-12-042024-12-0650,672$2.07 $104.9K15,516,059SEC↗
ADCT ADC Therapeutics SA J Other2024-12-042024-12-0650,672$2.07 $104.9K15,566,731SEC↗
ADCT ADC Therapeutics SA S Sale2024-12-042024-12-0625,352$2.07 $52.5K15,566,731SEC↗
AUGX Augmedix, Inc. D To issuer deriv2024-10-022024-10-041,093,799— $00SEC↗
AUGX Augmedix, Inc. D To issuer deriv2024-10-022024-10-041,093,799— $00SEC↗
AUGX Augmedix, Inc. D To issuer deriv2024-10-022024-10-043,125,195— $00SEC↗
AUGX Augmedix, Inc. D To issuer deriv2024-10-022024-10-043,125,195— $00SEC↗
AUGX Augmedix, Inc. D To issuer2024-10-022024-10-049,446,146$2.35 $22.20M0SEC↗
AUGX Augmedix, Inc. D To issuer2024-10-022024-10-046,218,238$2.35 $14.61M0SEC↗
AUGX Augmedix, Inc. D To issuer2024-10-022024-10-0416,421,788$2.35 $38.59M0SEC↗
IGMS IGM Biosciences, Inc. A Award2024-09-302024-10-021,734— $03,081,800SEC↗
ADCT ADC Therapeutics SA P Buy2024-07-012024-07-03400,000$2.81 $1.12M15,669,217SEC↗
ADCT ADC Therapeutics SA P Buy2024-07-012024-07-03400,000$2.81 $1.12M12,995,040SEC↗
IGMS IGM Biosciences, Inc. A Award2024-06-282024-07-021,734— $03,080,066SEC↗
STTK Shattuck Labs, Inc. A Award deriv2024-06-212024-06-2127,700— $027,700SEC↗
AUGX Augmedix, Inc. A Award2024-06-142024-06-1812,879— $016,421,788SEC↗
ABSI Absci Corp A Award deriv2024-06-122024-06-1436,274— $036,274SEC↗
ABSI Absci Corp A Award2024-06-122024-06-148,820— $08,262,136SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2024-06-072024-06-1140,000— $040,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-05-082024-05-106,107,181$4.81 $29.38M6,107,181SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-05-082024-05-108,163,265$4.81 $39.27M8,163,265SEC↗
IGMS IGM Biosciences, Inc. A Award2024-03-292024-04-011,734— $03,078,332SEC↗
IGMS IGM Biosciences, Inc. J Other2024-03-282024-04-0112,464— $03,076,598SEC↗
STTK Shattuck Labs, Inc. J Other2024-03-282024-04-014,425— $05,615,489SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2024-03-212024-03-253,636,364$5.50 $20.00M3,893,674SEC↗
AUGX Augmedix, Inc. A Award2024-03-152024-03-193,125— $016,408,909SEC↗
SNCE Science 37 Holdings, Inc. D To issuer deriv2024-03-122024-03-1395,765— $00SEC↗
SNCE Science 37 Holdings, Inc. D To issuer deriv2024-03-122024-03-132,068— $00SEC↗
IGMS IGM Biosciences, Inc. A Award deriv2024-03-122024-03-1429,400— $029,400SEC↗
SNCE Science 37 Holdings, Inc. U Tender2024-03-122024-03-131,017,203$5.75 $5.85M0SEC↗
ABSI Absci Corp P Buy2024-03-012024-03-05222,222$4.50 $1000.0K8,253,316SEC↗
IGMS IGM Biosciences, Inc. C Conversion deriv2024-02-282024-03-01113,400— $07,199,325SEC↗
IGMS IGM Biosciences, Inc. C Conversion2024-02-282024-03-01113,400— $03,089,062SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-02-072024-02-09107,590— $0107,590SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-02-022024-02-09144,517— $0144,517SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-02-022024-02-0911,159— $011,159SEC↗
ADCT ADC Therapeutics SA J Other deriv2024-02-012024-02-0919,700$3.38 $66.6K1,180,136SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-02-012024-02-09205,483— $0205,483SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-02-012024-02-0915,867— $015,867SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-312024-02-09150,000— $0150,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-302024-02-09100,000— $0100,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-292024-02-09150,000— $0150,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-262024-02-09100,000— $0100,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-252024-02-09100,000— $0100,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-242024-02-0950,000— $050,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-162024-02-0953,900— $053,900SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-122024-02-0993,424— $093,424SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-112024-02-09100,000— $0100,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-102024-02-09100,000— $0100,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-092024-02-09100,000— $0100,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-082024-02-09100,000— $0100,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-052024-02-0950,000— $050,000SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-042024-02-0928,652— $028,652SEC↗
ADCT ADC Therapeutics SA J Other deriv2024-01-032024-02-0959,986$1.68 $100.8K1,199,836SEC↗
ADCT ADC Therapeutics SA P Buy deriv2024-01-032024-02-0956,900— $056,900SEC↗
IGMS IGM Biosciences, Inc. A Award2023-12-292024-01-03492— $02,975,662SEC↗
FATE FATE THERAPEUTICS INC J Other2023-12-262023-12-281,655,370$3.72 $6.16M13,135,758SEC↗
FATE FATE THERAPEUTICS INC J Other2023-12-262023-12-281,655,370$3.72 $6.16M13,135,758SEC↗
FATE FATE THERAPEUTICS INC P Buy2023-12-262023-12-2844,630$3.72 $166.0K13,180,388SEC↗
STTK Shattuck Labs, Inc. A Award deriv2023-12-212023-12-263,100,823— $03,100,823SEC↗
AUGX Augmedix, Inc. A Award2023-12-152023-12-191,767— $016,405,784SEC↗
AUGX Augmedix, Inc. A Award deriv2023-11-202023-11-221,093,799— $01,093,799SEC↗
AUGX Augmedix, Inc. A Award deriv2023-11-202023-11-221,093,799— $01,093,799SEC↗
AUGX Augmedix, Inc. P Buy2023-11-202023-11-22750,000$4.00 $3.00M16,404,017SEC↗
AUGX Augmedix, Inc. P Buy2023-11-202023-11-22750,000$4.00 $3.00M9,446,146SEC↗
IGMS IGM Biosciences, Inc. A Award2023-09-292023-10-03492— $02,975,170SEC↗
RYZB RayzeBio, Inc. C Conversion deriv2023-09-192023-09-21864,509— $00SEC↗
RYZB RayzeBio, Inc. C Conversion deriv2023-09-192023-09-21498,510— $00SEC↗
RYZB RayzeBio, Inc. C Conversion deriv2023-09-192023-09-21432,254— $00SEC↗
RYZB RayzeBio, Inc. C Conversion2023-09-192023-09-21864,509— $0864,509SEC↗
RYZB RayzeBio, Inc. C Conversion2023-09-192023-09-21498,510— $01,857,706SEC↗
RYZB RayzeBio, Inc. C Conversion2023-09-192023-09-21494,687— $01,359,196SEC↗
AUGX Augmedix, Inc. A Award2023-08-312023-09-052,092$4.78 $10.0K15,654,017SEC↗
AUGX Augmedix, Inc. A Award2023-07-132023-07-1721,598— $015,651,925SEC↗
IGMS IGM Biosciences, Inc. A Award2023-06-302023-07-03492— $02,974,678SEC↗
IGMS IGM Biosciences, Inc. S Sale2023-06-292023-07-0380,423$9.42 $757.6K2,893,763SEC↗
IGMS IGM Biosciences, Inc. P Buy2023-06-292023-07-0380,423$9.42 $757.6K2,974,186SEC↗
IGMS IGM Biosciences, Inc. J Other2023-06-292023-07-0354,740$9.42 $515.7K2,919,446SEC↗
IGMS IGM Biosciences, Inc. J Other2023-06-292023-07-0354,740$9.42 $515.7K2,974,186SEC↗
IGMS IGM Biosciences, Inc. A Award deriv2023-06-262023-06-282,812,500$8.00 $22.50M7,312,725SEC↗
MDVL MedAvail Holdings, Inc. A Award deriv2023-06-162023-06-2138,916,562— $038,916,562SEC↗
MDVL MedAvail Holdings, Inc. A Award deriv2023-06-162023-06-2138,916,562— $038,916,562SEC↗
ABSI Absci Corp A Award deriv2023-06-142023-06-1653,100— $053,100SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2023-06-062023-06-0840,000— $040,000SEC↗
STTK Shattuck Labs, Inc. A Award deriv2023-05-262023-05-3140,258— $040,258SEC↗
SNCE Science 37 Holdings, Inc. A Award2023-05-112023-05-15494,853$0.25 $123.7K20,344,070SEC↗
AUGX Augmedix, Inc. J Other2023-05-022023-05-047,446,146$3.00 $22.34M15,630,327SEC↗
AUGX Augmedix, Inc. J Other2023-05-022023-05-047,446,146$3.00 $22.34M15,630,327SEC↗
AUGX Augmedix, Inc. J Other2023-05-022023-05-045,000,000$3.00 $15.00M0SEC↗
FATE FATE THERAPEUTICS INC P Buy2023-04-212023-04-21256,639$6.18 $1.59M13,135,758SEC↗
FATE FATE THERAPEUTICS INC P Buy2023-04-202023-04-2120,000$5.99 $119.8K12,879,119SEC↗
AUGX Augmedix, Inc. A Award deriv2023-04-192023-04-213,125,195$1.60 $5.00M3,125,195SEC↗
AUGX Augmedix, Inc. A Award2023-04-192023-04-211,250,000$1.60 $2.00M15,630,327SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2023-04-142023-04-17550,000$5.84 $3.21M559,100SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2023-04-142023-04-1745,752$29.20 $1.34M2,761,108SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2023-04-142023-04-1745,752$29.20 $1.34M2,761,108SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2023-04-142023-04-1754,960$5.84 $321.0K257,310SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2023-04-142023-04-1754,960$5.84 $321.0K257,310SEC↗
FATE FATE THERAPEUTICS INC J Other deriv2023-04-142023-04-17550,000$5.84 $3.21M559,100SEC↗
FATE FATE THERAPEUTICS INC S Sale2023-04-142023-04-17302,339$5.84 $1.77M12,833,419SEC↗
FATE FATE THERAPEUTICS INC J Other2023-04-142023-04-175,492,385$5.84 $32.08M12,833,419SEC↗
FATE FATE THERAPEUTICS INC P Buy2023-04-142023-04-1725,700$6.00 $154.2K12,859,119SEC↗
FATE FATE THERAPEUTICS INC J Other2023-04-142023-04-175,492,385$5.84 $32.08M12,833,419SEC↗
FATE FATE THERAPEUTICS INC C Conversion deriv2023-04-132023-04-1733,441— $02,761,108SEC↗
FATE FATE THERAPEUTICS INC C Conversion2023-04-132023-04-17167,205— $013,135,758SEC↗
IGMS IGM Biosciences, Inc. A Award deriv2023-04-042023-04-0615,500— $015,500SEC↗
IGMS IGM Biosciences, Inc. A Award2023-03-312023-04-04492— $03,336,999SEC↗
MDVL MedAvail Holdings, Inc. A Award deriv2023-03-092023-03-1338,916,562$0.32 $12.45M38,916,562SEC↗
MDVL MedAvail Holdings, Inc. A Award deriv2023-03-092023-03-1338,916,562$0.32 $12.45M38,916,562SEC↗
IGMS IGM Biosciences, Inc. A Award2022-12-302023-01-04230— $03,336,507SEC↗
ZYME Zymeworks Inc. A Award2022-10-132022-10-1730,481$5.03 $153.3K6,075,918SEC↗
ZYME Zymeworks Inc. P Buy2022-10-132022-10-1830,481$5.03 $153.3K6,075,918SEC↗
IGMS IGM Biosciences, Inc. J Other deriv2022-10-032022-10-0516,375$22.48 $368.1K667,666SEC↗
IGMS IGM Biosciences, Inc. J Other deriv2022-10-032022-10-0516,375$22.48 $368.1K667,666SEC↗
IGMS IGM Biosciences, Inc. J Other deriv2022-10-032022-10-05297,801$22.49 $6.70M4,500,225SEC↗
IGMS IGM Biosciences, Inc. J Other deriv2022-10-032022-10-05297,801$22.49 $6.70M4,500,225SEC↗
IGMS IGM Biosciences, Inc. J Other2022-10-032022-10-05221,072$22.49 $4.97M3,336,277SEC↗
IGMS IGM Biosciences, Inc. J Other2022-10-032022-10-05221,072$22.49 $4.97M3,336,277SEC↗
IGMS IGM Biosciences, Inc. A Award2022-09-302022-10-04230— $03,336,277SEC↗
MDVL MedAvail Holdings, Inc. A Award deriv2022-07-012022-07-063,819,558— $09,548,897SEC↗
MDVL MedAvail Holdings, Inc. A Award deriv2022-07-012022-07-064,705,881— $012,069,628SEC↗
MDVL MedAvail Holdings, Inc. A Award2022-07-012022-07-069,411,765$1.06 $9.98M34,604,516SEC↗
MDVL MedAvail Holdings, Inc. A Award2022-07-012022-07-067,639,117$1.06 $8.10M19,097,796SEC↗
IGMS IGM Biosciences, Inc. A Award2022-06-302022-07-05230— $03,336,047SEC↗
SNCE Science 37 Holdings, Inc. J Other2022-06-132022-06-156,472,228$3.38 $21.88M19,849,217SEC↗
SNCE Science 37 Holdings, Inc. J Other2022-06-132022-06-156,472,228$3.38 $21.88M19,849,217SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2022-06-092022-06-1311,893— $011,893SEC↗
FATE FATE THERAPEUTICS INC A Award2022-06-092022-06-138,650— $012,968,553SEC↗
ABSI Absci Corp A Award deriv2022-06-082022-06-1028,700— $028,700SEC↗
STTK Shattuck Labs, Inc. A Award deriv2022-06-082022-06-1040,258— $040,258SEC↗
SNCE Science 37 Holdings, Inc. A Award2022-05-232022-05-2540,983$3.05 $125.0K19,849,217SEC↗
MDVL MedAvail Holdings, Inc. A Award deriv2022-04-042022-04-067,058,821— $07,058,821SEC↗
MDVL MedAvail Holdings, Inc. A Award2022-04-042022-04-0614,117,646$1.06 $14.96M25,192,751SEC↗
IGMS IGM Biosciences, Inc. P Buy deriv2022-04-012022-04-042,608,695$23.00 $60.00M4,500,225SEC↗
IGMS IGM Biosciences, Inc. A Award2022-03-312022-04-04230— $03,335,817SEC↗
IGMS IGM Biosciences, Inc. A Award deriv2022-03-122022-03-1529,497— $029,497SEC↗
IGMS IGM Biosciences, Inc. A Award2021-12-312022-01-04130— $03,335,587SEC↗
TRDA Entrada Therapeutics, Inc. C Conversion deriv2021-11-022021-11-04954,420— $00SEC↗
TRDA Entrada Therapeutics, Inc. C Conversion2021-11-022021-11-04954,420— $0954,420SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2021-11-022021-11-041,000,000$20.00 $20.00M1,954,420SEC↗
AUGX Augmedix, Inc. P Buy2021-10-282023-04-211,625,000$4.00 $6.50M6,218,238SEC↗
AUGX Augmedix, Inc. P Buy2021-10-282021-11-011,625,000$4.00 $6.50M14,380,327SEC↗
SNCE Science 37 Holdings, Inc. A Award deriv2021-10-072021-10-1241,363— $041,363SEC↗
SNCE Science 37 Holdings, Inc. A Award2021-10-062021-10-0814,750,786— $019,750,786SEC↗
SNCE Science 37 Holdings, Inc. A Award2021-10-062021-10-1814,808,234— $019,808,234SEC↗
IGMS IGM Biosciences, Inc. A Award2021-09-302021-10-04130— $03,426,557SEC↗
ADGI Adagio Therapeutics, Inc. C Conversion deriv2021-08-102021-08-121,920,960— $00SEC↗
ADGI Adagio Therapeutics, Inc. P Buy2021-08-102021-08-121,470,000$17.00 $24.99M3,390,960SEC↗
ADGI Adagio Therapeutics, Inc. C Conversion2021-08-102021-08-121,920,960— $01,920,960SEC↗
ABSI Absci Corp C Conversion deriv2021-07-262021-07-280— $00SEC↗
ABSI Absci Corp C Conversion deriv2021-07-262021-07-284,209,573— $00SEC↗
ABSI Absci Corp P Buy2021-07-262021-07-281,875,000$16.00 $30.00M8,031,094SEC↗
ABSI Absci Corp C Conversion2021-07-262021-07-281,946,521— $06,156,094SEC↗
ABSI Absci Corp C Conversion2021-07-262021-07-284,209,573— $04,209,573SEC↗
IGMS IGM Biosciences, Inc. A Award2021-06-302021-07-02130— $03,426,427SEC↗
VERV Verve Therapeutics, Inc. C Conversion deriv2021-06-212021-06-238,208,832— $00SEC↗
VERV Verve Therapeutics, Inc. P Buy2021-06-212021-06-231,050,000$19.00 $19.95M1,936,530SEC↗
VERV Verve Therapeutics, Inc. C Conversion2021-06-212021-06-23886,530— $0886,530SEC↗
STTK Shattuck Labs, Inc. A Award deriv2021-06-192021-06-223,434— $03,434SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2021-06-022021-06-044,334— $04,334SEC↗
FATE FATE THERAPEUTICS INC A Award2021-06-022021-06-042,681— $012,959,903SEC↗
IGMS IGM Biosciences, Inc. A Award2021-03-312021-04-02130— $03,426,297SEC↗
IGMS IGM Biosciences, Inc. A Award deriv2021-02-192021-02-236,423— $06,423SEC↗
FATE FATE THERAPEUTICS INC P Buy deriv2021-01-082021-01-12257,310$85.50 $22.00M257,310SEC↗
FATE FATE THERAPEUTICS INC P Buy2021-01-082021-01-12327,485$85.50 $28.00M12,957,222SEC↗
IGMS IGM Biosciences, Inc. A Award2020-12-312021-01-05178— $03,426,167SEC↗
APRE Aprea Therapeutics, Inc. S Sale2020-12-282021-02-165,863$5.80 $34.0K1,768,718SEC↗
APRE Aprea Therapeutics, Inc. S Sale2020-12-282021-02-16494,137$5.58 $2.76M1,774,581SEC↗
STTK Shattuck Labs, Inc. A Award deriv2020-12-222020-12-281,286— $01,286SEC↗
IGMS IGM Biosciences, Inc. P Buy deriv2020-12-112020-12-15667,666$89.99 $60.08M667,666SEC↗
STTK Shattuck Labs, Inc. C Conversion deriv2020-10-142020-10-15318,064— $00SEC↗
STTK Shattuck Labs, Inc. P Buy2020-10-142020-10-1565,047$20.00 $1.30M5,538,219SEC↗
STTK Shattuck Labs, Inc. P Buy2020-10-142020-10-15158,100$18.01 $2.85M5,278,014SEC↗
STTK Shattuck Labs, Inc. P Buy2020-10-142020-10-15195,158$19.20 $3.75M5,473,172SEC↗
STTK Shattuck Labs, Inc. P Buy2020-10-142020-10-152,941,176$17.00 $50.00M5,119,914SEC↗
STTK Shattuck Labs, Inc. C Conversion2020-10-142020-10-152,178,738— $02,178,738SEC↗
STTK Shattuck Labs, Inc. P Buy2020-10-142020-10-1550,000$22.10 $1.10M5,619,914SEC↗
STTK Shattuck Labs, Inc. P Buy2020-10-142020-10-1531,695$21.09 $668.4K5,569,914SEC↗
AUGX Augmedix, Inc. P Buy2020-10-052020-10-075,000,000$3.00 $15.00M12,755,327SEC↗
IGMS IGM Biosciences, Inc. A Award2020-10-012020-10-05178— $03,425,989SEC↗
IGMS IGM Biosciences, Inc. P Buy2020-09-092020-09-098,650$51.85 $448.5K3,425,811SEC↗
IGMS IGM Biosciences, Inc. P Buy2020-09-092020-09-0914,610$52.96 $773.7K3,417,161SEC↗
IGMS IGM Biosciences, Inc. P Buy2020-09-082020-09-0947,113$49.91 $2.35M3,402,551SEC↗
IGMS IGM Biosciences, Inc. P Buy2020-09-042020-09-0974,433$50.28 $3.74M3,355,438SEC↗
IGMS IGM Biosciences, Inc. P Buy2020-09-032020-09-0374,253$48.69 $3.62M3,281,005SEC↗
IGMS IGM Biosciences, Inc. P Buy2020-09-022020-09-031,464$45.54 $66.7K3,187,579SEC↗
IGMS IGM Biosciences, Inc. P Buy2020-09-022020-09-0319,173$46.76 $896.5K3,206,752SEC↗
IGMS IGM Biosciences, Inc. P Buy2020-09-012020-09-0341,759$44.84 $1.87M3,186,115SEC↗
KYMR Kymera Therapeutics, Inc. C Conversion deriv2020-08-252020-08-252,600,740— $00SEC↗
KYMR Kymera Therapeutics, Inc. C Conversion2020-08-252020-08-251,630,660— $01,630,660SEC↗
ALVR Allovir, Inc. C Conversion deriv2020-08-032020-08-051,226,993— $00SEC↗
ALVR Allovir, Inc. C Conversion2020-08-032020-08-05823,371— $0823,371SEC↗
NRIX Nurix Therapeutics, Inc. C Conversion deriv2020-07-282020-07-301,176,470— $00SEC↗
ANNX Annexon, Inc. C Conversion deriv2020-07-282020-07-3014,062,719— $00SEC↗
NRIX Nurix Therapeutics, Inc. C Conversion2020-07-282020-07-301,176,470— $01,176,470SEC↗
ANNX Annexon, Inc. C Conversion2020-07-282020-07-301,596,222— $01,596,222SEC↗
IGMS IGM Biosciences, Inc. A Award2020-07-012020-07-06178— $03,144,356SEC↗
RPTX Repare Therapeutics Inc. C Conversion deriv2020-06-232020-06-251,586,174— $00SEC↗
RPTX Repare Therapeutics Inc. C Conversion2020-06-232020-06-251,586,174— $01,586,174SEC↗
FATE FATE THERAPEUTICS INC P Buy2020-06-112020-06-171,412,928$28.31 $40.00M12,629,737SEC↗
PLRX PLIANT THERAPEUTICS, INC. C Conversion deriv2020-06-052020-06-0913,661,202— $00SEC↗
PLRX PLIANT THERAPEUTICS, INC. C Conversion2020-06-052020-06-091,910,657— $01,910,657SEC↗
FATE FATE THERAPEUTICS INC A Award deriv2020-05-012020-05-0516,000— $016,000SEC↗
NLTX Neoleukin Therapeutics, In S Sale2020-04-022020-04-069,734$11.30 $110.0K4,041,311SEC↗
NLTX Neoleukin Therapeutics, In P Buy2020-04-022020-04-0638,300$11.36 $435.1K4,050,045SEC↗
NLTX Neoleukin Therapeutics, In P Buy2020-04-022020-04-061,000$11.85 $11.8K4,051,045SEC↗
NLTX Neoleukin Therapeutics, In S Sale2020-04-022020-04-06100$11.82 $1.2K4,041,211SEC↗
IGMS IGM Biosciences, Inc. A Award2020-04-012020-04-03178— $03,144,178SEC↗
NLTX Neoleukin Therapeutics, In P Buy2020-04-012020-04-069,000$11.65 $104.8K4,021,579SEC↗
NLTX Neoleukin Therapeutics, In P Buy2020-04-012020-04-0633,500$10.95 $366.8K4,012,579SEC↗
NLTX Neoleukin Therapeutics, In S Sale2020-04-012020-04-069,634$11.06 $106.6K4,011,945SEC↗
NLTX Neoleukin Therapeutics, In S Sale2020-04-012020-04-06200$11.87 $2.4K4,011,745SEC↗
NLTX Neoleukin Therapeutics, In P Buy2020-03-312020-04-0622,500$10.18 $229.1K3,971,579SEC↗
NLTX Neoleukin Therapeutics, In P Buy2020-03-312020-04-067,500$10.71 $80.3K3,979,079SEC↗
NLTX Neoleukin Therapeutics, In P Buy2020-03-302020-04-0629,800$9.91 $295.3K3,946,379SEC↗
NLTX Neoleukin Therapeutics, In P Buy2020-03-302020-04-062,700$10.27 $27.7K3,949,079SEC↗
NLTX Neoleukin Therapeutics, In P Buy2020-03-272020-04-0650,000$9.21 $460.5K3,916,579SEC↗
BEAM Beam Therapeutics Inc. C Conversion deriv2020-02-102020-02-115,208,333— $00SEC↗
BEAM Beam Therapeutics Inc. C Conversion2020-02-102020-02-111,161,458— $01,161,458SEC↗
IGMS IGM Biosciences, Inc. A Award deriv2020-02-052020-04-0310,000— $010,000SEC↗
CABA Cabaletta Bio, Inc. C Conversion deriv2019-10-292019-10-291,044,568— $00SEC↗
CABA Cabaletta Bio, Inc. C Conversion2019-10-292019-10-29696,378— $0696,378SEC↗
ALDR ALDER BIOPHARMACEUTICALS I U Tender deriv2019-10-222019-10-2420,243— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I D To issuer deriv2019-10-222019-10-2454,757— $020,243SEC↗
ALDR ALDER BIOPHARMACEUTICALS I X Exercise deriv2019-10-222019-10-2475,000— $075,000SEC↗
ALDR ALDER BIOPHARMACEUTICALS I X Exercise deriv2019-10-222019-10-2475,000— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I J Other deriv2019-10-222019-10-2475,000— $075,000SEC↗
ALDR ALDER BIOPHARMACEUTICALS I U Tender deriv2019-10-222019-10-24779,776— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I D To issuer deriv2019-10-222019-10-2422,500— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I D To issuer deriv2019-10-222019-10-2415,000— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I D To issuer deriv2019-10-222019-10-2430,000— $00SEC↗
ALDR ALDER BIOPHARMACEUTICALS I U Tender2019-10-222019-10-248,244,896— $00SEC↗
APRE Aprea Therapeutics, Inc. C Conversion deriv2019-10-072019-10-081,164,674— $00SEC↗
APRE Aprea Therapeutics, Inc. P Buy2019-10-072019-10-08400,000$15.00 $6.00M2,268,718SEC↗
APRE Aprea Therapeutics, Inc. C Conversion2019-10-072019-10-081,868,718— $01,868,718SEC↗